Intelligence · Clinical Development
Pipeline search results
Programs matching “mesenchymal” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 37 pipeline programs matching "mesenchymal" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
umbilical cord mesenchymal stem cells
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Cartilage Damage
1 trial -
ACE001-RI001
Shanghai Zhongshan Hospital
Interstitial Lung Disease (ILD)
1 trial -
Allogeneic MSC
United Therapeutics Europe Ltd
Mesenchymal Stromal Cells
1 trial -
Extracellular Vesicles from Mesenchymal Stem Cells
Regeneron Ireland Designated Activity Company (DAC)
COVID-19 Pneumonia
1 trial -
Human Umbilical Mesenchymal Stem Cells
The First People's Hospital of Lianyungang
Osteoarthritis, Knee
1 trial -
Human amniotic-derived mesenchymal stem cells
The First People's Hospital of Lianyungang
Chronic Kidney Diseases
1 trial -
Human umbilical cord mesenchymal stem cells
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Pneumoconiosis
1 trial -
Mesenchymal Stem Cell Infusion
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Immune Effector Cell Associated Hematotoxicity
1 trial -
TH-SC01(Umbilical cord mesenchymal stem cells)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Rectal Injury
1 trial -
human Mesenchymal Stem Cell (MSC) infusion therapy
CytoMed Therapeutics Ltd
Aging Well
1 trial -
mesenchymal stem cells
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Peripheral Vascular Disease
1 trial -
mesenchymal stromal cells
Xiyuan Hospital of China Academy of Chinese Medical Sciences
MSC
1 trial -
Human umbilical cord mesenchymal stem cells
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Knee Osteoarthritis
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.